Evotec SE (FRA:EVT)
Germany · Delayed Price · Currency is EUR 6.07
-0.17 (-2.73%)
At close: Jan 30, 2026
Evotec SE Revenue
In the year 2024, Evotec SE had annual revenue of 796.97M EUR with 1.99% growth. Evotec SE had revenue of 163.89M in the quarter ending September 30, 2025, a decrease of -5.75%.
Revenue
796.97M
Revenue Growth
+78.52%
P/S Ratio
1.46
Revenue / Employee
157.96K
Employees
4,788
Market Cap
1.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 796.97M | 15.54M | 1.99% |
| Dec 31, 2023 | 781.43M | 29.98M | 3.99% |
| Dec 31, 2022 | 751.45M | 250.52M | 50.01% |
| Dec 31, 2020 | 500.92M | 54.49M | 12.20% |
| Dec 31, 2019 | 446.44M | 71.03M | 18.92% |
| Dec 31, 2018 | 375.41M | 334.83M | 825.21% |
| Dec 31, 2006 | 40.58M | -1.26M | -3.02% |
| Dec 31, 2005 | 41.84M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gelsenwasser AG | 3.36B |
| Paul Hartmann AG | 2.44B |
| FRoSTA Aktiengesellschaft | 652.00M |
| tonies SE | 510.38M |
| Maschinenfabrik Berthold Hermle AG | 469.42M |
| Südwestdeutsche Salzwerke AG | 347.96M |
| EUROKAI GmbH & Co. KGaA | 262.47M |
| Northern Data AG | 200.27M |
Evotec SE News
- 24 days ago - Evotec SE (EVO) Secures Gates Foundation Grant for Biotherapeutics - GuruFocus
- 24 days ago - Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access - Accesswire
- 24 days ago - Evotec Secures Grant to Use AI for Cost-Effective Monoclonal Antibody Development - Wallstreet:Online
- 24 days ago - EQS-News: Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access - Wallstreet:Online
- 4 weeks ago - Evotec SE: Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Finanz Nachrichten
- 4 weeks ago - Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Accesswire
- 4 weeks ago - Evotec Names Dr. Sarah Fakih as New EVP of Global Communications & IR - Wallstreet:Online
- 4 weeks ago - EQS-News: Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Wallstreet:Online